Filter Results:
(2,289)
Show Results For
- All HBS Web
(2,289)
- News (378)
- Research (1,625)
- Events (19)
- Multimedia (25)
- Faculty Publications (951)
Show Results For
- All HBS Web
(2,289)
- News (378)
- Research (1,625)
- Events (19)
- Multimedia (25)
- Faculty Publications (951)
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- July 2024
- Article
The Home State Effect: How Subnational Governments Shape Climate Coalitions
By: Jonas Meckling and Samuel Trachtman
Organized business interests often seek to block public interest regulations. But whether firms oppose regulation depends on institutional context. We argue that, in federal systems, sub-national policies and politics can have a home state effect on firms' national... View Details
Meckling, Jonas, and Samuel Trachtman. "The Home State Effect: How Subnational Governments Shape Climate Coalitions." Governance 37, no. 3 (July 2024): 887–905.
- 27 Feb 2019
- HBS Seminar
David Robinson, Fuqua School of Business at Duke University
Fintech Borrowers: Lax-Screening or Cream-Skimming?
Financial markets have recently witnessed a disruptive force: the rise of online intermediaries and, more generally, fintech companies, i.e., firms that apply technology to improve financial activities. Fintech companies have targeted the consumer credit market,... View Details
- 27 Mar 2018
- First Look
First Look at New Research, March 27, 2018
forthcoming Harvard Journal on Legislation From the Digital to the Physical: Federal Limitations on Regulating Online Marketplaces By: Edelman, Benjamin, and Abbey Stemler Abstract—Online marketplaces have transformed how we shop, travel,... View Details
Keywords: Sean Silverthorne
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- August 2010
- Article
Sell-Side School Ties
By: Lauren H. Cohen, Christopher J. Malloy and Andrea Frazzini
We study the impact of social networks on agents' ability to gather superior information about firms. Exploiting novel data on the educational backgrounds of sell-side equity analysts and senior officers of firms, we test the hypothesis that analysts' school ties to... View Details
Keywords: Investment Return; Investment Portfolio; Corporate Disclosure; Governing Rules, Regulations, and Reforms; Knowledge Acquisition; Social and Collaborative Networks
Cohen, Lauren H., Christopher J. Malloy, and Andrea Frazzini. "Sell-Side School Ties." Journal of Finance 65, no. 4 (August 2010): 1409–1437. (Winner of Smith Breeden Prize for the Best Paper Published in the Journal of Finance in Asset Pricing (Distinguished Paper) 2010.)
- 25 Feb 2015
- Working Paper Summaries
Thick as Thieves? Dishonest Behavior and Egocentric Social Networks
- 03 Dec 2009
- News
How to take moral hazard out of banking
- 23 Mar 2021
- News
Should Gig Work Be Government-Run?
- 23 Jun 2015
- News
Governance reforms add significance to being a public company
- March 2011 (Revised March 2011)
- Case
Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform
Per the Patient Protection and Affordable Care Act (PPACA), which President Obama signed in 2010, states would be required to create state-wide health insurance marketplaces - the Health Benefit Exchanges (HBEs) - in which individuals and small employers could choose... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Emerging Markets; Risk and Uncertainty; Health Industry; Insurance Industry; New Jersey
Oberholzer-Gee, Felix, Raffaella Sadun, and Richard G. Hamermesh. "Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform." Harvard Business School Case 711-403, March 2011. (Revised March 2011.)
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Biotechnology Industry; Health Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- January 1993 (Revised November 1995)
- Case
AXA: The Global Insurance Company
Claude Bebear, the CEO of AXA, the tenth-largest insurer in Europe, has just completed an acquisition of the Equitable, the seventh-largest insurer in the United States. As part of his strategy to make AXA the first truly global insurance company, Bebear is considering... View Details
Keywords: Market Entry and Exit; Insurance; Global Strategy; Acquisition; Insurance Industry; Asia; North America; Europe
Goodman, John B., and Patrick Moreton. "AXA: The Global Insurance Company." Harvard Business School Case 793-094, January 1993. (Revised November 1995.)
- 12 Nov 2014
- News